Once-Daily Oral Solution

ENTYCE® (capromorelin oral solution) is indicated for appetite stimulation in dogs.1

The therapeutic provides a convenient, once-daily oral solution for treating inappetence. ENTYCE for dogs is supplied as a 30-mg/mL flavored oral solution for ease of administration and is available in three convenient bottle sizes: 10mL, 15mL and 30mL.

ENTYCE® (capromorelin oral solution) packaging

ENTYCE Dosing Information

Recommended Dose:

3 mg/kg (1.4 mg/lb) body weight once daily

Use this dosing calculator to find the recommended dosage based on your patient’s weight.

Select weight of dog

3 MG/KG = 0.1 ML/KG

DOSE

1.4 mL

How to Administer

To administer ENTYCE, the bottle should be shaken gently and then the appropriate amount of solution withdrawn using the provided syringe. The syringe should be rinsed between doses.1

1 ENTYCE package insert

IMPORTANT SAFETY INFORMATION: ENTYCE® (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more detail.

ENTYCE® (capromorelin oral solution) Clinical References

Clinical References

Your convenient one-stop source for viewing important information.

Learn more >

ENTYCE® (capromorelin oral solution) In-Clinic Tools

In-Clinic Tools

Use these downloadable tools for identifying inappetence in dogs and how to use ENTYCE.

Learn more >

ENTYCE® (capromorelin oral solution) Professional Education

Professional Education

Find out about upcoming conferences and free webinars where you can learn more about ENTYCE.

Learn more >

Other therapeutics from Aratana

Nocita® (bupivacaine liposome injectable suspension)
NOCITA® (bupivacaine liposome injectable suspension) is the only long-acting local anesthetic that controls cranial cruciate ligament (CCL) post-op pain with one dose for up to 72 hours.

You can be sure that the local relief will help keep your patient is comfortable even after going home.

Visit Website >

IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for use in dogs only. Do not use in dogs younger than 5 months of age, dogs used for breeding, or in pregnant or lactating dogs. Do not administer by intravenous or intra-arterial injection. Adverse reactions in dogs may include discharge from incision, incisional inflammation and vomiting. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.